Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (8298)	12/13/1997 9:33:00 PM
From: BDR	Read Replies (1) \| Respond to of 9285

<<I also think that since phentolamine is an anti-hypertension drug, the FDA is going to be very hard to convince that Vasomax is safe. People who have normal blood pressure shouldn't be taking drugs like this and people who suffer from hypertension that are already taking other anti-hypertension drugs certainly shouldn't be taking drugs like this. A drop in blood pressure blow the normal range can cause dizzyness and loss of consciouness.> Phentolamine will drop blood pressure, but so will alprostadil (the active ingredient in MUSE and Caverject) and the FDA approved both. Vivus even urges doctors to administer the drug to the patient in the office setting so that blood pressure can be checked before turning the patient loose with the stuff at home. MUSE and Caverject are both commonly given to hypertensives on medication. I am not long ZONA, in fact may go short Monday.